Cursos

Home Cursos
Voltar

6º Simpósio em Pesquisa, Desenvolvimento e Inovação em Doenças Bacterianas e Fúngicas - 6ª Edição

Unidade/ofertante: Instituto Oswaldo Cruz Telefone: Tel: (21) 2562-1200 / 1444 / 1401
C Capacitação/Cursos Livres
À distância
Aguarde Novas Inscrições

Sobre o curso

O SIMBAF 2020 visa promover o intercâmbio científico e tecnológico e a difusão de experiências e conhecimento entre pesquisadores nacionais e internacionais, jovens e seniores. O público alvo consiste de pós-graduandos, pesquisadores e profissionais da área da saúde, que serão estimulados à participação ativa, através dos chats e sessões de Q&A, nas discussões temáticas do simpósio, contribuindo para a construção de uma visão multidisciplinar e abrangente dos tópicos abordados.

Tendo em vista o grande número de participantes, os certificados de participação serão disponibilizados a partir de novembro, para aqueles que obtiveram frequencia mínima de 75%.

Assista ao simpósio pelo Canal do IOC no Youtube, nos dias 5 a 8 de Outubro de 2020, entre 14:30 e 17 h (horário local do Rio de Janeiro). As palestras serão em inglês. Perguntas e comentários sobre as apresentações devem ser feitos pelo chat do Youtube. Use a #simbaf2020 para continuar as discussões científicas através das redes sociais. 
Certificados serão emitidos para os que tiverem >75% de presença nas atividades. O link da lista de presença será divulgado pelo chat do Youtube.
-----
The Symposium will be live-streamed on Youtube (click here) on October 5 to 8th, between 2:30 and 5 pm (Rio de Janeiro local time). Please, join the Symposium on Youtube. We welcome you to make questions and comments about the talks using Youtube chat. You may also use the #simbaf2020 to follow the discussion on social networks.  


---

É com enorme satisfação que informamos que o 6º Simpósio em Pesquisa, Desenvolvimento e Inovação em Doenças Bacterianas e Fúngicas (SIMBAF 2020), organizado pelo Instituto Oswaldo Cruz - Fiocruz, será realizado entre os dias 5 e 8 de outubro de 2020.

O evento será gratuito e transmitido por meio do canal oficial do IOC no YouTube. Tópicos avançados em micologia e bacteriologia, incluindo novas abordagens para prevenção, diagnóstico, tratamento, vigilância e estudo de mecanismos de patogênese serão intensamente discutidos nas quatro sessões programadas, a serem realizadas entre 14:30 e 17 h.

O SIMBAF 2020 visa promover o intercâmbio científico e tecnológico e a difusão de experiências e conhecimento entre pesquisadores nacionais e internacionais, jovens e seniores. O público alvo consiste de pós-graduandos, pesquisadores e profissionais da área da saúde, que serão estimulados à participação ativa, através dos chats e sessões de Q&A, nas discussões temáticas do simpósio, contribuindo para a construção de uma visão multidisciplinar e abrangente dos tópicos abordados.
O evento é gratuito, inscreva-se!



Aproveitamos a oportunidade para convidar alunos de pós-graduação interessados em discutir seus trabalhos na temática do SIMBAF a participar também da disciplina do IOC Tópicos Avançados em Pesquisa, Desenvolvimento e Inovações em Doenças Bacterianas e Fúngicas – que ocorrerá de forma associada ao SIMBAF (nas manhãs dos dias 5 a 9 de Outubro). Os alunos inscritos na disciplina apresentarão suas respectivas  pesquisas, de forma oral, no horário da disciplina. 
O LINK PARA INSCRIÇÃO NA DISCIPLINA É: https://docs.google.com/forms/d/e/1FAIpQLSdVlwwIDTh0gsgJ8AQr40KEUgVKhL3P7GUlhYZF2h98-sp_uA/viewform 



 ------

Invitation
We would like to announce and invite you to the 6th Research, development, and innovation symposium on bacterial and fungal infections. The Symposium will be held online, by the official IOC channel on YouTube, between October 5th and 8th, 2020. The Symposium will be a showcase of current basic and translational research on topics in bacterial and fungal pathogens, and foster exchanges among participants. Advanced topics including new approaches for prevention, diagnosis, treatment, surveillance, and study of pathogenesis mechanisms will be intensely discussed. We hope that as a result of the Symposium participants can engage in collaborations on the main bacterial and fungal pathogens that affect our population.
Registration is free, but mandatory. 
Ana Paula Assef (LAPIH/IOC/Fiocruz)
Maria Helena Féres Saad (LAMICEL/IOC/Fiocruz)
Lucimar Ferreira Kneipp (LTBBF/IOC/Fiocruz)
Letícia Lery (LAMICEL/IOC/Fiocruz)
Teca Galvão (LAGFB/IOC/Fiocruz)
Viviane Zahner (LEMEF/IOC/Fiocruz)

Scientific Commitee:
Ana Beatriz Furlanetto Pacheco (UFRJ)
Bruno Mietto (UFJF)
Bianca Cruz Neves (UFRJ)
Catia Lacerda Sodré (UFF)
Claudia Mendonça Souza (UFF)
Deyse Vallim (IOC/Fiocruz)
Giovani Carlo Veríssimo da Costa (UFF)
Gisela Lara da Costa (IOC/Fiocruz)
Manoel Marques de Oliveira (IOC/Fiocruz)
Marcel Menezes Lyra da Cunha (UFRJ)
Paulo Redner (ENSP/Fiocruz)
Rachel Ribeiro (UFF)
Rafael Barauna (UFPA)
Raquel Teixeira (IOC/Fiocruz)
Silvana Spindola (UFMG)
Thiago Pavoni (UFF)

 
Clique aqui e acesse a programação do evento.
Program click here


Assista ao simpósio pelo Canal IOC no Youtube, nos dias 5 a 8 de Outubro de 2020, entre 14:30 e 17 h (horário local do Rio de Janeiro). As palestras serão em inglês. Perguntas e comentários sobre as apresentações devem ser feitos pelo chat do Youtube. Use a #simbaf2020 para continuar as discussões científicas através das redes sociais. 
​Certificados serão emitidos para os que tiverem >75% de presença nas atividades. O link da lista de presença será divulgado pelo chat do Youtube.
...

The Symposium will be live-streamed on Youtube (click here)  on October 5 to 8th, between 2:30 and 5 pm (Rio de Janeiro local time). Please, join the Symposium on Youtube. We welcome you to make questions and comments about the talks using Youtube chat. You may also use the #simbaf2020 to follow the discussion on social networks.  
------
 
The symposium will streaming on IOC channel at YOUTUBE (Canal IOC). There will be four scientific sessions, between 2:30 and 5 pm (Rio de Janeiro local time), from October 5th to 8th. Brazilian and foreign researchers will present their most recent research and advances. We will have talks from invited speakers and also selected from submitted abstracts. If you work in the field and have interesting results to share with the scientific community, please submit your abstract!
Daily sessions will feature presentations, audience Q&A, and a panel discussion involving the presenters. The full schedule details will be announced in the near future.
Abstracts selected for oral presentation:

October 6th:
Diversity of Cronobacter genus isolated on the American continent and genotyped using multi-locus sequence typing - Marcelo Luiz Lima Brandão 
 

Characterization of the impact of 3,4-dimethylbenzoic acid on virulence and anaerobic respiration of Salmonella enterica serovar Typhimurium - Fernanda Stephens Hermes da Silva 
 
Adipose tissue as a site of Mycobacterium leprae infection - Sabrina Alves dos Reis 

October 7th:
Characteristics of Staphylococcus aureus isolated from the skin and nostrils of children with atopic dermatitis - Maria Isabella Menezes Macedo Assunção
 
Molecular mechanisms of pan-azole resistant in Candida haemulonii complex species from Brazil - Laura Nunes Silva



----

Se você trabalha numa das áreas temáticas do simpósio e gostaria de apresentar seu trabalho de forma oral durante o simpósio, por favor, envie um resumo para apreciação pelo comitê científico. Os resumos devem ser enviados até 25 de agosto.

O resumo deve ser escrito em inglês, em fonte ARIAL 12 pt, espaçamento simples, conter título do trabalho, autores e afiliações, e ter no máximo uma página.
Deve ser submetido um arquivo .pdf no momento da inscrição, que deverá ser anexado no campo específico. O arquivo deverá ser nomeado com o nome completo do participante.
Pelo menos 1 dos autores do trabalho deve estar inscrito no evento.
 
O resultado da seleção de resumos para apresentação oral será divulgado no mês de setembro, aqui no site.
 
-----

 
Abstracts
 
The abstract submission deadline is August 25th.
Abstracts must be written in English, font Arial 12 pt, simple line spacing, maximum 1 page, .pdf format. Title, authors, and affiliations must be included. At least one of the authors must be registered in the symposium.
Selected abstracts will be announced in September.
Em caso de dúvidas ou informações, entre em contato com a organização do evento:
e-mail: simbaf@ioc.fiocruz.br

------
Please, do not hesitate to get in touch in case you have further questions:
simbaf@ioc.fiocruz.br
Palestrantes Confirmados / Speakers
 
Dr. Sylvain Brisse
Sylvain Brisse is a researcher at Institute Pasteur (Paris, France), heading the Biodiversity and Epidemiology of Bacterial Pathogens laboratory.
“Previously controlled bacterial infections can re-emerge due to antibiotic resistance or vaccine escape. Species of pathogenic bacteria comprise a huge amount of genotypic and phenotypic diversity. Our lab is interested in the diversity, evolution and epidemiology of bacterial pathogens and in the links between the genotypic and phenotypic (ecology, colonization, transmission, virulence, antibiotic resistance, immune response) diversity of the strains within particular species. We focus on three pathogens of high public health importance: Klebsiella pneumoniae, which causes various types of infections including urinary tract, respiratory and blood infections; Bordetella pertussis, the agent of whooping cough; and Corynebacterium diphtheriae, the agent of diphtheria. We use genomics, proteomics, bioinformatics and immunological approaches as well as in-vivo and in-vitro models of infection. We also develop databases of bacterial genotypes and strain nomenclatures that facilitate global collaborative surveillance of bacterial pathogens”

For more information: https://research.pasteur.fr/en/team/biodiversity-and-epidemiology-of-bacterial-pathogens/

Dra Ana Gales
Great experience in the field of Infectious Diseases, with an emphasis on bacterial resistance. Professor, coordinator of the Postgraduate Program in Infectology, researcher,  director of the Alert Laboratory and the Special Laboratory of Clinical Microbiology of Escola Paulista de Medicina / UNIFESP, Research Productivity Scholarship CNPq  level 1A. Coordinator of the Brazilian Antimicrobial Sensitivity Test Committee (BrCast) and member of the Technical Chamber of Microbial Resistance (CATREM), ANVISA.

Dr Felipe Piedade Gonçalves Neves

Large experience in Applied Microbiology and Public Health. Research Productivity Scholarship - CNPq Level 2 and Young Scientist from Nosso Estado (FAPERJ). Prof. Associated of the Department of Microbiology and Parasitology of the Biomedical Institute of the Universidade Federal Fluminense (UFF). Coordinator of the Graduate Program in Applied Microbiology and Parasitology (PPGMPA / UFF).

Leah Cowen, PhD.
Professor and Chair of the Molecular Genetics Department at the University of Toronto, Canada. Her research focuses on developing new strategies to combat drug resistance and treat life-threatening fungal infections through an innovative and interdisciplinary approach, including chemical and  functional genomics,  experimental evolution, microbiome analysis of patient populations and structure-guided drug design. She has been recognized with a myriad of awards including a Burroughs Wellcome Fund Career Award, Grand Challenges Canada Star in Global Health Award, Merck Irving S. Sigal Memorial Award and E.W.R. Steacie Award.

Marcio Rodrigues, PhD.
Senior Researcher of Carlos Chagas Institute at FIOCRUZ Paraná in Brazil and a Coordinator of its Stricto Sensu Postgraduate Program in Biosciences and Biotechnology. He is a member of the American Academy of Microbiology and the Advisory Committee on Microbiology and Parasitology of CNPq. He is an advisor to the American Society of Medical Mycology, and a board member of the Brazilian Society of Microbiology. He has got a CNPq Research Productivity Scholarship, level 1B. His research group focuses on the mechanisms of non-conventional secretion in yeasts, aiming at the development of new antifungal drugs and prophylactic tools.

Leila Bezerra, PhD.
Founder and Researcher of the Startup BIDiagnostics at the Center for Innovation, Entrepreneurship and Technology, University of São Paulo (USP), through FAPESP Innovative Research Program for Small Businesses. She is a USP Visiting Researcher as FAPESP fellowship and Coordinator of the Working Group on Sporothrix and Sporotrichosis of the International Society for Human and Animal Mycology. She has got a CNPq Research Productivity Scholarship, level 1C and coordinates the INCT Emerging Fungal Infections. Her main goals include applied microbiology and mycosis immunodiagnosis.

Kelly Ishida, PhD.
Professor and the Leader of Antifungal Chemotherapy Laboratory in the Department of Microbiology at the University of São Paulo (USP), Brazil. She is a Coordinator of Antifungal Subcommittee of  Brazilian Committee on Antimicrobial Susceptibility Testing  (BrCAST). She has got a CNPq Research Productivity Scholarship, level 2 and her main Lab goals are to develop therapeutic alternatives for fungal infections approaching molecules of natural and synthetic  origin, repositioning of drugs and  production of drug carriers.



Alejandro Buschiazzo (Institute Pasteur, Montevideo) is a structural biologist whose work integrates molecular biology and protein biochemistry to understand mechanisms regulating pathogenesis in several organisms, including M. tuberculosis and Leptospira. He is head of the Molecular and Structural Microbiology Laboratory and of the Protein Crystallography Unit, as well as Associate Professor at the Microbiology Department at Institut Pasteur (Paris). Alejandro has been awarded several awards, including the François Jacob Prize (Institut Pasteur Paris, 2014), and is a member of the National Academy of Sciences of Uruguay and of the  IUC´s Commission of  Biological Macromolecules.

Douglas McIntosh (UFRRJ)
Professor of Molecular Biology at the Department of Animal Parasitology (DPA) at the Federal Rural University of Rio de Janeiro (UFRRJ). Its general area of research  is the development of improved methods for the diagnosis and prevention of microbial and parasitic diseases considered relevant in the context of One Health.

Dr. Iñaki Comas (Biomedicine Institute of Valencia) :
Dr. Iñaki Comas is Head of the Tuberculosis Genomics Unit at the Biomedicine Institute of Valencia. Dr. Comas did his PhD at the University of Valencia on Evolutionary Genomics of bacteria. In 2008, he moved to Dr. Sebastien Gagneux's laboratory in the National Institute for Medical Research in London. His team was among the first to use genome sequencing in a large scale to address issues related to host-pathogen interaction, evolution, and drug resistance. In 2012, Dr. Comas returned to Spain and since 2016 holds a permanent principal investigator position at the Biomedicine Institute of Valencia. He has regional, national, and international funding including an ERC Starting Grant focusing on tuberculosis transmission. Current projects at the Tuberculosis Genomics Unit (http://tgu.ibv.csic.es/) cover basic, applied and clinical/translational research with major focus on transmission and drug resistance of tuberculosis. Analyses from his group led to breakthrough insights in our understanding of antigenic variation (Nat Genet. 2010), identification of drug resistance targets (Nat Genet. 2012, JID 2019), evolution with the human host (Nat Genet. 2013, PNAS 2015, Current Biology 2015), identification of genomic determinants of virulence (Chiner-Oms 2019, Science Advances) and on the transmission of the disease (JID 2014, EBIOMedicine 2018).  

Dr. Fabrizio Menardo (SwissTPH):
He studied Natural sciences and environmental biology at the University of Torino (Italy). Then, moved to Switzerland to do his PhD in evolutionary Biology at the University of Zurich, in the group of Prof Beat Keller. During the PhD he researched the evolution of a fungal pathogen of wheat and other cereals (Blumeria graminis, grass powdery mildew). After the PhD he moved to Basel (Switzerland) for a PostDoc at the SwissTPH in the group of Prof Sebastien Gagneux, where he is currently working. Currently, he focus is on the population genetics, genomics and evolution of Mycobacterium tuberculosis.

Dr. Silvana Spíndola (UFMG)
Graduated in Medicine from the Faculty of Medicine of Valença (1988), Master in Medical Clinic Emphasis in Pulmonology and Phthisiology from the Federal University of Rio de Janeiro (1994), and PhD in Genie Biologique Medicale - Université Joseph Fourier - Grenoble I- France (1997). Post-doctorate at the Pasteur Institute in Paris (2006) at the Genetique Micobacterienne Laboratory. Collaborator at the Pontifical Catholic University of Rio Grande do Sul, Université Paris-Sud, State Foundation for Health Research and Production, Federal University of Rio Grande, Municipal Health Secretariat of Minas Gerais, Municipal Health Secretariat of Belo Horizonte, Fundação Ezequiel Dias and Federal University of Rio de Janeiro. Full professor at the Federal University of Minas Gerais, supervisor of the graduate course Adult Health and Tropical Health at the Federal University of Minas Gerais. 
Experience in Medicine, with emphasis on Tuberculosis, acting on the following subjects: tuberculosis, phenotypic and genotypic diagnosis of mycobacteria, Mycobacterium tuberculosis, molecular epidemiology. Coordinator of the Laboratory of Mycobacteria of the Faculty of Medicine and of the Tuberculosis Clinic, a secondary reference at the Hospital das Clínicas, UFMG. Coordinator of the Diagnostic area REDE TB.

Fernanda C de Q Mello - MD, MSc, PhD  
Full Professor at the Faculty of Medicine of the Federal University of Rio de Janeiro (UFRJ). Director of the Institute of Chest Diseases (IDT) at UFRJ. President of the Society of Pulmonology and Tisiology of the State of Rio de Janeiro (SOPTERJ). Experience in the area of Tisiology and Pulmonology, with projects related to diseases of the respiratory system covering epidemiological aspects, molecular biology, laboratory and radiological diagnosis and clinical trials, with an emphasis on tuberculosis and non-tuberculous mycobacteriosis.